Analyst Coverage
Viking Therapeutics, Inc. is covered by the following analysts:
| B. Riley Securities | Mayank Mamtani | 646-885-5463 |
| BTIG | Jeet Mukherjee, Ph.D. | 332-400-5178 |
| Canaccord Genuity LLC | Edward Nash | 212-389-8128 |
| Cantor Fitzgerald | Steve Seedhouse, Ph.D. | 212-915-1240 |
| Goldman Sachs & Co. LLC | Richard Law, Ph.D. | 212-357-6054 |
| H.C. Wainwright & Co. | Joseph Pantginis, Ph.D. | 646-975-6968 |
| Jefferies | Roger Song, M.D., CFA | 617-342-7955 |
| J.P. Morgan | Hardik Parikh, CFA | 212-622-2875 |
| Laidlaw & Company | Yale Jen, Ph.D. | 212-953-4978 |
| Leerink Partners | Thomas J. Smith | 212-277-6069 |
| Maxim Group | Naz Rahman, CFA | 212-895-3642 |
| Morgan Stanley | Michael E. Ulz | 212-761-4650 |
| Oppenheimer | Jay Olson, CFA | 212-667-8126 |
| Piper Sandler & Co. | Biren Amin | 732-284-6909 |
| Raymond James | Ryan Deschner, Ph.D. | 212-856-4397 |
| Stifel | Annabel Samimy | 212-271-3823 |
| Truist Securities | Research | |
| William Blair | Andy Hsieh, Ph.D. | 312-364-5051 |
Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent Viking Therapeutics or its management team. Viking Therapeutics is under no obligation to update this list, thus it may not be complete or up to date.